This evaluation has now been discontinued. Due to positive guidance in the adult population within TA814, NICE will not progress with a separate appraisal for this indication. NHS England will commission treatments for patients aged less than 18 years where specific commissioning conditions within a NICE Technology Appraisal or NHS England policy are met.
 
Status Discontinued
Decision Selected
Process TA
ID number 3823

Timeline

Key events during the development of the guidance:

Date Update
21 September 2022 Discontinued. This evaluation has now been discontinued. Due to positive guidance in the adult population within TA814, NICE will not progress with a separate appraisal for this indication. NHS England will commission treatments for patients aged less than 18 years where specific commissioning conditions within a NICE Technology Appraisal or NHS England policy are met.
21 September 2022 This evaluation has now been discontinued. Due to positive guidance in the adult population within TA814, NICE will not progress with a separate appraisal for this indication. NHS England will commission treatments for patients aged less than 18 years where specific commissioning conditions within a NICE Technology Appraisal or NHS England policy are met.

For further information on our processes and methods, please see our CHTE processes and methods manual